Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial

Overview of attention for article published in Journal of Clinical Oncology, June 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 38 X posts from 32 X users, with an upper bound of 258,244 followers.

RT @FarmaOnco: "Risk Factors & Outcomes for Follicular Lymphoma Transformation After Response to First-Line in the PRIMA Trial" https://t.c…

RT @roverome: Biopsy Recurrent Follicular #Lymphoma. If histologic transformation is present consider ASCT. #lymsm https://t.co/ppclIoO35z

Risk Factors and Outcomes for Patients With Follicular #Lymphoma With Histologic Transformation in the PRIMA Trial https://t.co/J6xSmZiHX7

RT @FarmaOnco: "Risk Factors & Outcomes for Follicular Lymphoma Transformation After Response to First-Line in the PRIMA Trial" https://t.c…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 34 additional X posts.